ROLE OF 1-INTEGRIN EXPRESSION IN TRASTUZUMAB RESISTANCE IN RADIATION INDUCED HER-2-POSITIVE BREAST CANCER

被引：0
|
作者：
Thoms, J. [1 ]
Sabri, S. [1 ]
Lesniak, D. [1 ]
Murray, D. [1 ]
Abdulkarim, B. [1 ]
机构：
[1] Cross Canc Inst, Edmonton, AB, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
123
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [41] HER-3 status by immunohistochemistry in HER-2-positive metastatic breast cancer patients treated with trastuzumab: correlation with clinical outcome
    Gori, Stefania
    Foglietta, Jennifer
    Mameli, Maria Grazia
    Stocchi, Lucia
    Fenocchio, Daniela
    Anastasi, Paola
    Iacono, Daniela
    Del Sordo, Rachele
    Basurto, Carlo
    De Angelis, Verena
    Sidoni, Angelo
    TUMORI, 2012, 98 (01) : 39 - 44
  • [42] CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells
    Boulbes, Delphine R.
    Chauhan, Gaurav B.
    Jin, Quanri
    Bartholomeusz, Chandra
    Esteva, Francisco J.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (03) : 501 - 513
  • [43] CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells
    Delphine R. Boulbes
    Gaurav B. Chauhan
    Quanri Jin
    Chandra Bartholomeusz
    Francisco J. Esteva
    Breast Cancer Research and Treatment, 2015, 151 : 501 - 513
  • [44] miR-21 expression in HER2-positive breast cancer and prediction of resistance to adjuvant trastuzumab
    Nielsen, Boye S.
    Balslev, Eva
    Poulsen, Tim S.
    Nielsen, Dorte
    Moller, Trine S.
    Mortensen, Christiane E.
    Holmstrom, Kim S.
    Hoegdall, Estrid
    CANCER RESEARCH, 2015, 75
  • [45] Why adjuvant trastuzumab led to better outcomes in women with high-risk HER-2-positive breast cancer
    Altundag, Kadri
    Baptista, Mauricio Z.
    BREAST JOURNAL, 2006, 12 (05): : 497 - 498
  • [46] Association of basal marker expression with outcome and trastuzumab resistance in HER2-positive breast cancer.
    Chung, Alice P.
    Choi, Michael Phillip
    Bose, Shikha
    Zhang, Xiao
    Varda, Marian
    Cui, Xiaojiang
    Giuliano, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] The role of p95HER2 in trastuzumab resistance in breast cancer
    Eliyatkin, Nuket Ozkavruk
    Aktas, Safiye
    Ozgur, Hakan
    Ercetin, Pinar
    Kupelioglu, Ali
    JOURNAL OF BUON, 2016, 21 (02): : 382 - 389
  • [48] The role of adam10 in trastuzumab resistance of her2 positive breast cancer cell lines
    Feldinger, Katharina
    Gijsen, Merel
    Kong, Anthony
    CANCER RESEARCH, 2011, 71
  • [49] Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer
    Sonnenblick, Amir
    Salmon-Divon, Mali
    Salgado, Roberto
    Dvash, Efrat
    Ponde, Noam
    Zahavi, Tamar
    Salmon, Asher
    Loibl, Sibylle
    Denkert, Carsten
    Joensuu, Heikki
    Ameye, Lieveke
    Van den Eynden, Gert
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Azaria, Amos
    Loi, Sherene
    Michiels, Stefan
    Richard, Francois
    Sotiriou, Christos
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (01) : 266 - 276
  • [50] Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer
    Sonnenblick, Amir
    Salmon-Divon, Mali
    Salgado, Roberto
    Ponde, Noam
    Loibl, Sibylle
    Denkert, Carsten
    Joensuu, Heikki
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Azaria, Amos
    Loi, Sherene
    Michiels, Stefan
    Sotiriou, Christos
    CANCER RESEARCH, 2020, 80 (04)
12345